Company Details
- Employees
- 13
- Founded
- -
- Address
- Heiane 2b, Nyborg,norway
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- http://www.tiotech.com
- HQ
- Bergen, Vestland
Please complete the CAPTCHA to continue
Ignota buys Kronos' pipeline, igniting 2nd chance salvo to rescue shelved programs Fierce Biotech
BRAIN Biotech AG Appoints Johan Jansen-Storbacka as Executive Vice President of the BRAINBiocatalysts' Enzyme Products Business Yahoo Finance
Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies GlobeNewswire
Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors Biotech Newswire
$18M Financing Deal: Purple Biotech Prices Public Offering with $1.00 Warrants for Cancer Drug Development Stock Titan
Concentra extends biotech shopping spree by collecting Cargo Fierce Biotech
Acticor Biotech Announces that the Court Judgment Has Been Postponed Until January 2, 2025 Business Wire
Purple Biotech Expands CAPTN-3 Portfolio with IM1305, a Novel Tri-Specific Antibody Targeting TROP2 Yahoo Finance
Clinical-Stage Cancer Drug Developer Purple Biotech to Present at Major Healthcare Conference Stock Titan
Sanofi-backed SpliceBio secures $135M series B for eye disease gene therapy trials Fierce Biotech
Purple Biotech Announces Pricing of Up To $18 Million Public Offering Yahoo Finance
Verve's 2nd swing at PCSK9 editing yields clean safety profile, teeing up Lilly opt-in decision Fierce Biotech
RFK Jr. cuts 4,700 FDA and NIH jobs as HHS eliminates 'an entire alphabet soup of departments' Fierce Biotech
Fierce Biotech Layoff Tracker 2025: Alector halves staff; Galapagos axes cell therapy unit Fierce Biotech
Fierce Biotech Fundraising Tracker '25: Hemab closes $157M series C; Electra shines with $183M Fierce Biotech
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers Fierce Biotech
Biomea's diabetes drug improves glucose control 3 months after FDA hold lifted Fierce Biotech
Kronos shelves sole remaining clinical asset over neurological side effects Fierce Biotech
MacroGenics pauses work on vobra duo ADC pending mature survival data Fierce Biotech
Biotech faces a reckoning: 'We've lost our luster in cell therapies' Fierce Biotech
Kelun-Biotech Announces Approximately US$250 Million Placement PR Newswire
The end of eFFECTOR Therapeutics: Oncology biotech winds down after midstage fail Fierce Biotech
CHANGING THE FUTURE OF BIOTECH NEOM
AstraZeneca plants an EGFR tree with Pinetree deal worth $45M Fierce Biotech
Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission Fierce Biotech
AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies Fierce Biotech
Introducing Fierce Biotech's 2023 Fierce 15 Fierce Biotech
Fierce Biotech Fundraising Tracker '24: AusperBio adds $73M series B; Ottimo raises $140M Fierce Biotech
Purple Biotech Reports First Quarter 2025 Financial Results Yahoo Finance
Purple Biotech CEO Issues Letter to Shareholders GlobeNewswire
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference GlobeNewswire
Fierce Biotech's 2021 Fierce 15 Fierce Biotech
Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups Yahoo Finance
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC PR Newswire
The top biotech hubs in 2022 Fierce Biotech
DolCas Biotech Marine Collagen Boosts the Morning Coffee Break PR Newswire
Fierce Biotech's 2022 Fierce 15 Fierce Biotech
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai Yahoo Finance
Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results GlobeNewswire
$18M Financing: Purple Biotech Secures $6M Public Offering Plus $12M in Short-Term Warrant Potential Stock Titan
Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study of CM24 in Second Line Pancreatic Cancer Yahoo Finance
Purple Biotech's Cancer Drug Achieves 5x Better Response Rate in Pancreatic Cancer Patients with Biomarkers Stock Titan
26,000 Human Transcriptomes: Purple Biotech's Novel Cancer Drug Shows Promise in Resistant Tumors Stock Titan
Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer GlobeNewswire
Purple Biotech Appoints Shai Lankry as Chief Financial Officer GlobeNewswire
Hal Barron quits GSK to take CEO post at $3B biotech startup, leaving Wood to finish what he began Fierce Biotech
SIRION Biotech Pharmaceutical Technology
Purple Biotech Announces Research Collaboration with the GlobeNewswire
Breakthrough 1-5pM Efficacy: Purple Biotech's Novel Triple-Action Cancer Antibody Shows Promise in TNBC Stock Titan
Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial GlobeNewswire
Purple Biotech Granted New U.S. Patent for NT219 in GlobeNewswire
Purple Biotech Reports Positive Final Results from GlobeNewswire
VERO Biotech Raises $30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System PR Newswire
ACTICOR BIOTECH: Topline Results of ACTISAVE Phase 2/3 Study in Stroke Treatment Business Wire
VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System PR Newswire
The Biocodex Group Strengthens Its Position in Microbiota, With the Signature of a Licensing Agreement With My Health, a Belgian Biotech Company Specializing in Microbiota Solutions Business Wire
VERO Biotech's Second Generation GENOSYL® Delivery System (DS) Receives FDA Approval in Anesthesia in the Surgical Suite PR Newswire
Purple Biotech Expands Pipeline of First-in-Class GlobeNewswire
Evaxion Biotech A/S Announces Executive Management Changes GlobeNewswire
EVAX Stock Price and Chart — NASDAQ:EVAX TradingView
PPBT Stock Price and Chart — TASE:PPBT TradingView
PSC Biotech Corporation and PSC Software Announce Acquisition of Three of the Four Largest Pharmaceutical Companies as Customers of Adaptive Compliance Engine™ aka ACE PR Newswire
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.